# Guive Balooch

> Guive Balooch is a post-ipo equity investor at L'Oreal (New York) backing Biotechnology. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [L'Oreal](https://shizune.co/investors/profile/loreal)
- Location: New York, United States
- Total investments: 1
- Last investment: Jun 2026
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/pub/guive-balooch/4/b31/771
- Website: https://x.com/guivecbi_loreal

Guive Balooch is a post-ipo equity investor at L'Oreal in New York focused on Biotechnology. Guive Balooch is the global vice president of the Connected Beauty Incubator at L’Oréal Research and Innovation, dedicated to bringing new scientifically driven ecosystems to beauty consumers worldwide. A native of California, Balooch has a scientific background, with a BA in molecular and cell biology from the University of California, Berkeley,and a PhD in biomaterials from the University of California, San Francisco. Following a postdoc at Stanford in cell biomechanics, he joined the pharmaceutical industry working on new antibody research for bone-related diseases. He then joined L’Oréal in 2008, initially a part of building new collaborations for L’Oréal with startups and universities. With his increased interest in linking to consumers and the business, he is now running a worldwide connected beauty incubator focused on new technologies for the beauty market and scoping and implementing new consumer experiences for every beauty need. His passion lies in the link between bringing new and exciting scientific technology to empower beauty consumers and improve their routines and behaviors.

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| OliX Pharmaceuticals | OliX is a clinical stage biotechnology company, based on their own proprietary RNA interference (RNAi) technology regulating the expression of disease-causing genes. | $72.6M | Post-IPO Equity | Jun 02, 2026 |  |

1 of 1 investments shown.

## Co-investors
- [Weiss Asset Management](https://shizune.co/investors/profile/weiss-asset-management) — VC Fund, 1 deal together

## About L'Oreal

VC Fund · Clichy, France

L’Oréal manufactures and sells cosmetic products for women and men worldwide. It offers skincare and haircare products, deodorants, make-up products, perfumes, oral cosmetics, hair colors, styling and shaping products, nail care products, and dermocosmetics.The company provides its products under the Lancôme, Giorgio Armani, Yves Saint LaurentBeauté, Biotherm, Kiehl’s, Ralph Lauren, Shu Uemura, Cacharel, Helena Rubinstein, Clarisonic, Diesel, Viktor&Rolf, Yue Sai, Maison Martin Margiela, Urban Decay, Guy Laroche, Paloma Picasso, Vichy, La Roche-Posay, SkinCeuticals, Roger&Gallet, Sanoflore, L’Oréal Paris, Garnier, Maybelline New York, Softsheen.Carson, Essie, L’Oréal Professionnel, Kérastase, Redken, Matrix, Pureology, Shu Uemura Art of Hair, Mizani, Essie, CARITA, and Decleor brand names.

5 contacts available at L'Oreal.

| Name | Title | Profile |
| --- | --- | --- |
| Antoine Borde | Global eCommerce Acceleration Director and Digital Transformation | https://shizune.co/investors/profile/antoine-borde |
| Guive Balooch | Global Vice President | https://shizune.co/investors/profile/guive-balooch |
| Laurent Schmitt | Global Head of Corporate Finance and Financial Communication; CEO of BOLD, VC Fund of L’Oreal | https://shizune.co/investors/profile/laurent-schmitt-0040 |
| Lubomira Rochet | Chief Digital Officer, member of the Group Executive Committee | https://shizune.co/investors/profile/lubomira-rochet |
| Mourad Ajarti | Asia Pacific CIO | https://shizune.co/investors/profile/mourad-ajarti |

## Similar investors

### Similar stage
- [RA Capital Management](https://shizune.co/investors/profile/ra-capital-management) — VC Fund
- [KB Securities](https://shizune.co/investors/profile/kb-securities) — VC Fund
- [Frazier Healthcare Partners](https://shizune.co/investors/profile/frazier-healthcare-ventures) — VC Fund

## FAQ

### What does Guive Balooch invest in?

Guive Balooch invests primarily in Biotechnology startups, most often at Post-IPO Equity stage. Most of the 1 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Guive Balooch last invest?

The most recent investment recorded for Guive Balooch closed in Jun 2026. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co